Medical Update: HER2-Positive Metastatic Breast Cancer

About 20 percent of breast cancers are HER2 positive, testing positive for a protein called human epidermal growth factor receptor 2, or HER2. In this session, learn from Reshma L. Mahtani, DO about the latest treatment options targeting HER2-positive metastatic breast cancer and hear about research in the pipeline. Get informed about recently approved medicines and how they fit into ongoing treatment.

• Kategori